SEARCH HEALTH CONDITIONS BY ALPHABETS
Familial Hypophosphatemia
Medications for Familial Hypophosphatemia
About Familial Hypophosphatemia: Familial Hypophosphatemia is an inherited condition in which there is just a very low amount of potassium from blood.
Drugs Used to Treat Familial Hypophosphatemia
This set of medications come in some way associated with, or found at the treatment of this illness.
| Medication name | Rx / OTC | Pregnancy | CSA | Alcohol | Reviews | Rating | Popularity |
|---|---|---|---|---|---|---|---|
| ergocalciferol | Rx/OTC | C | N | Add review | 6.0 | ||
Generic title: ergocalciferol systemic Brand titles: Vitamin D2, Drisdol, Calcidol, Calciferol...show all Medicine course: vitamins For consumers: dosage, interactions, For professionals: a Z Drug Truth, AHFS DI Monograph, Prescribing Information | |||||||
| Vitamin D 2 | Rx/OTC | C | N | Add review | 0.0 | ||
Generic title: ergocalciferol systemic Medicine course: vitamins For consumers: dosage, interactions, side effects | |||||||
| Drisdol | Rx/OTC | C | N | Add review | 0.0 | ||
Generic title: ergocalciferol systemic Medicine course: vitamins For consumers: dosage, interactions, and side effects For professionals: AHFS DI Monograph, Prescribing Information | |||||||
| Calcidol | Rx/OTC | C | N | Add review | 0.0 | ||
Generic title: ergocalciferol systemic Medicine course: vitamins For consumers: dosage, interactions, side effects | |||||||
| Calciferol | Rx/OTC | C | N | Add review | 0.0 | ||
Generic title: ergocalciferol systemic Medicine course: vitamins For users: dosage, interactions, negative effects | |||||||
Legend
| Rx | prescription-only |
|---|---|
| OTC | Over the Counter |
| Rx/OTC | Prescription or Over The Counter |
| Away Tag | This medication might well not be approved by the FDA for treating the illness. |
| Pregnancy Category | |
|---|---|
| A | Adequate and well-controlled studies have failed to demonstrate a risk to the embryo within the first trimester of pregnancy (and there is no evidence of risk in later trimesters). |
| B | Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no sufficient and well-controlled studies in pregnant women. |
| C | Animal reproduction studies have shown an adverse effect in the fetus and there are no sufficient and well-controlled studies in humans, but potential benefits may warrant used in pregnant women despite potential risks. |
| D | There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may justify used in pregnant women despite potential risks. |
| X | Studies in animals or humans have demonstrated fetal abnormalities or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and also the risks involved in used in pregnant women obviously outweigh potential rewards. |
| N | FDA have not classified this medication. |
| Controlled Substances Act (CSA) Schedule | |
|---|---|
| N | Is not at the mercy of the Controlled Substances Act. |
| Inch | includes a higher possibility of abuse. Has no accepted medical use in treatment in the USA. There`s a lack of accepted safety for use under medical supervision. |
| Two | includes a higher possibility of abuse. Features a currently accepted medical use with severe restrictions or a currently accepted medical use in treatment in the USA. Abuse may result in acute psychological or physical dependence. |
| 3 | Has a potential for abuse less than individuals in programs 1 and 2 2. Features a currently accepted medical use in treatment in the USA. Abuse may lead to moderate or low physical dependence or high psychological dependence. |
| 4 | includes a very low potential for abuse in accordance with those in schedule 3. It has a currently accepted medical use in treatment in the USA. Abuse may lead to limited physical dependence or psychological dependence relative to individuals in schedule 3. |
| 5 | includes a very low potential for abuse in accordance with individuals in schedule 4. Features a currently accepted medical use in treatment in the USA. Abuse may lead to limited physical dependence or psychological dependence. |
| Alcohol | |
|---|---|
| X | Interacts with Alcohol. |
Browse Treatment Plans
- A
- B
- C
- D
- E
- F
- G
- H
- I
- J
- K
- L
- M
- N
- O
- P
- Q
- R
- S
- T
- U
- V
- W
- X
- Y
- Z
Further advice
Always consult your physician to be sure the information applies to your circumstances.
- Fabry Disease
- Facial Fat Loss
- Facial Lipoatrophy
- Facial Wasting
- Factor IX Deficiency
- Factor IX Hemophilia
- Factor VII Deficiency
- Factor X Deficiency
- Factor XIII Deficiency
- Fallopian Tube Cancer
- Familial Cold Autoinflammatory Syndrome
- Familial Cold Urticaria
- Familial Hibernian Fever
- Familial Hypophosphatemia
- Familial Periodic Paralysis
- Familial Pulmonary Arterial Hypertension
- Family History of Cerebrovascular Disease
- Family History of Musculoskeletal Disorder
- Family History of Myocardial Infarction
- Fasciculations
- Fascioliasis
- Fasciolopsis Buski, Intestinal Fluke
- Fasting Blood Sugar
Top USA Pharma Companies
Popular Categories
Health Condition
- Fabry Disease
- Facial Fat Loss
- Facial Lipoatrophy
- Facial Wasting
- Factor IX Deficiency
- Factor IX Hemophilia
- Factor VII Deficiency
- Factor X Deficiency
- Factor XIII Deficiency
- Fallopian Tube Cancer
- Familial Cold Autoinflammatory Syndrome
- Familial Cold Urticaria
- Familial Hibernian Fever
- Familial Hypophosphatemia
- Familial Periodic Paralysis
- Familial Pulmonary Arterial Hypertension
- Family History of Cerebrovascular Disease
- Family History of Musculoskeletal Disorder
- Family History of Myocardial Infarction
- Fasciculations
- Fascioliasis
- Fasciolopsis Buski, Intestinal Fluke
- Fasting Blood Sugar
Easily find an affordable health insurance plan
